Huang Jane 4
4 · Prelude Therapeutics Inc · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Huang Jane
President, CMO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-10-04−9,375→ 18,750 total→ Common Stock (9,375 underlying) - Exercise/Conversion
Common Stock
2025-10-04+9,375→ 90,272 total - Tax Payment
Common Stock
2025-10-04$1.47/sh−3,355$4,932→ 86,917 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
- [F2]Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
- [F3]The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date.